The Patent Finder

Pantarhei Bioscience B.V.

Also on record
Records under this name other than the patents Pantarhei Bioscience B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Back to Pantarhei Bioscience B.V.

PatentTitleStatus Expires Confidence
US 9,034,854Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,732,430Drug Delivery System Comprising a Tetrahydroxilated Estrogen for Use in Hormonal Contraception
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,236,785Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,367,647Treatment of meconium aspiration syndrome with estrogens
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,987,240Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 8,518,923Treatment or prevention of hypertensive disorders of pregnancy or fetal growth retardation
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,801,627Sampler
Lapsed on the fee record
Ended Aug 12, 2026 · High confidence
Lapsed on the fee recordEnded Aug 12, 2026High confidence
US 9,040,509Method of treating human skin and a skin care composition for use in such a method
Formerly held
Term ended
Term ended Jan 24, 2026 · From the USPTO record
Term endedTerm ended Jan 24, 2026From the USPTO record
US 7,871,995Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
Formerly held
Term ended
Term ended Oct 7, 2025 · From the USPTO record
Term endedTerm ended Oct 7, 2025From the USPTO record
US 8,048,869Pharmaceutical composition for use in hormone replacement therapy
Formerly held
Term ended
Term ended May 14, 2025 · From the USPTO record
Term endedTerm ended May 14, 2025From the USPTO record
10 of 21 patents shown.
Pro members see all 21.
Pro members: see all 21 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited